BMO Capital Downgrades Abbvie (ABBV) to Underperform; 'Risk/Reward Skewed to the Downside'
Tweet Send to a Friend
BMO Capital downgraded Abbvie (NYSE: ABBV) from Market Perform to Underperform with a price target of $95.00 (from $84.00).Analyst Alex ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
